MarketBeat1d agoneutral
Halozyme Therapeutics AGM: Shareholders Elect Directors as CEO Torley Raises 2026 GuidanceHalozyme Therapeutics (NASDAQ:HALO) stockholders elected two Class I directors and approved several governance items at the company’s annual meeting, while President and CEO Helen Torley highlighted 2025 execution, recent acquisitions, new commercial agreements, and updated financial guidance. Stoc